scholarly article | Q13442814 |
P356 | DOI | 10.3109/09540261.2013.866075 |
P698 | PubMed publication ID | 24716502 |
P2093 | author name string | Maria R Lopez-Patton | |
Maria Rueda-Lara | |||
P2860 | cites work | Caregiver and patient marital satisfaction and affect following hematopoietic stem cell transplantation: a prospective, longitudinal investigation. | Q54753978 |
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment | Q57947248 | ||
Hematopoietic stem cell transplantation: a global perspective | Q24624697 | ||
Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? | Q28194707 | ||
Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis | Q28196269 | ||
Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment | Q28242431 | ||
Explaining family caregiver role strain following autologous blood and marrow transplantation | Q30230281 | ||
Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. | Q33183929 | ||
Hematologic toxicity of sodium valproate | Q33331641 | ||
Thrombotic thrombocytopenic purpura associated with quetiapine | Q33366475 | ||
A systematic review of the mortality of depression | Q33534388 | ||
Hematologic side effects of psychotropics | Q33729895 | ||
Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns | Q33754654 | ||
The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). | Q33914006 | ||
Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience | Q33961525 | ||
Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies | Q33965200 | ||
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence | Q33974684 | ||
Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. | Q34049213 | ||
A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients | Q34371532 | ||
Neutropenia: etiology and pathogenesis | Q34611345 | ||
Depression and immune function: central pathways to morbidity and mortality | Q34959869 | ||
Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years | Q35023468 | ||
Measuring social activities and social function in long-term cancer survivors who received hematopoietic stem cell transplantation | Q35043960 | ||
A systematic review of psychosocial factors affecting survival after bone marrow transplantation | Q35118598 | ||
Depression and cancer: mechanisms and disease progression | Q35189650 | ||
Haematological safety of antipsychotic drugs | Q35194357 | ||
Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). | Q35525461 | ||
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study | Q35849241 | ||
Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics | Q36087195 | ||
Health-related quality of life following allogeneic hematopoietic stem cell transplantation | Q36286379 | ||
Psychotropic drug-induced neutropenia | Q36290535 | ||
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Wo | Q36424524 | ||
Do negative or positive emotions differentially impact mortality after adult stem cell transplant? | Q36512137 | ||
Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. | Q36746364 | ||
Evidence-based treatment of delirium in patients with cancer | Q36822176 | ||
Quality of life concerns and depression among hematopoietic stem cell transplant survivors | Q37141324 | ||
Discharge needs of allogeneic transplantation recipients | Q37200543 | ||
Quality of life after allogeneic hematopoietic cell transplantation | Q37262503 | ||
Do coping and social support predict depression and anxiety in patients undergoing hematopoietic stem cell transplantation? | Q37399255 | ||
The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review | Q37855739 | ||
Adaptation of family caregivers during the acute phase of adult BMT. | Q39277407 | ||
Testing a diathesis-stress model: potential genetic risk factors for development of distress in context of acute leukemia diagnosis and transplant | Q39609534 | ||
Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners | Q39897149 | ||
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. | Q40939352 | ||
The experience of caring for a spouse undergoing hematopoietic stem cell transplantation: opening Pandora's box. | Q43579280 | ||
Depression as a risk factor for mortality after coronary artery bypass surgery | Q43646314 | ||
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation | Q43994969 | ||
Neutropenia associated with mirtazapine use: is a drop in the neutrophil count in a symptomatic older adults a cause for concern? | Q44091782 | ||
Delirium in patients undergoing hematopoietic stem cell transplantation | Q44197109 | ||
Social support and depression among bone marrow transplant patients | Q45242139 | ||
Repeated episodes of neutropenia triggered by mirtazapine. | Q45945495 | ||
Psychosocial function after hematopoietic stem cell transplantation | Q46376580 | ||
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls | Q47577769 | ||
An international study of the relation between somatic symptoms and depression | Q47697842 | ||
Persistent pain and well-being: a World Health Organization Study in Primary Care | Q47755362 | ||
Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities | Q48493326 | ||
Quality of life after stem cell transplantation: a patient, partner and physician perspective | Q48670596 | ||
Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients | Q48710328 | ||
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study | Q48769871 | ||
A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation | Q49286631 | ||
Social support, affectivity, and the quality of life of patients and their support-givers prior to stem cell transplantation. | Q50940694 | ||
Routine screening for psychosocial distress following hematopoietic stem cell transplantation. | Q50988694 | ||
Longitudinal study of adaptation to the stress of bone marrow transplantation. | Q51081963 | ||
Mental disturbances during isolation in bone marrow transplant patients with leukemia. | Q51082840 | ||
The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. | Q51083354 | ||
Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. | Q51135034 | ||
Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. | Q51905637 | ||
Quality of life associated with acute and chronic graft-versus-host disease. | Q51915254 | ||
Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. | Q51927149 | ||
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. | Q51933938 | ||
Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples. | Q51936955 | ||
Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. | Q51958594 | ||
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. | Q51968509 | ||
Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. | Q51972936 | ||
Allogeneic BMT and patient eligibility based on psychosocial criteria: a survey of BMT professionals. | Q52288444 | ||
Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. | Q53197463 | ||
Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. | Q53440895 | ||
Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. | Q53580686 | ||
P433 | issue | 1 | |
P921 | main subject | stem cell transplantation | Q65592366 |
P304 | page(s) | 74-86 | |
P577 | publication date | 2014-02-01 | |
P1433 | published in | International Review of Psychiatry | Q15752216 |
P1476 | title | Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants | |
P478 | volume | 26 |
Q92428030 | Evaluating patient satisfaction on an acute leukemia/bone marrow transplant day/night treatment unit: A pilot project |
Q98292908 | Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry |
Q39325684 | Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all? |
Q50173239 | Palliative care during and following allogeneic hematopoietic stem cell transplantation |
Q41333675 | Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis. |
Q64892619 | Évaluation de la satisfaction des patients concernant l’unité de traitement jour/nuit où l’on soigne les personnes qui reçoivent une greffe de moelle osseuse et qui sont atteintes d’une leucémie aiguë : projet pilote. |
Search more.